John Boyce

Vorstandsvorsitzender bei Exosome Diagnostics, Inc.

51 Jahre

Health Services

Commercial Services

Profil

John Boyce is currently the Chief Executive Officer and Director at Exosome Diagnostics, Inc. He previously worked as the Managing Director at Exosome Diagnostics GmbH.

Aktive Positionen von John Boyce

Unternehmen	Position	Beginn
Exosome Diagnostics, Inc. Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA.	Vorstandsvorsitzender	-

Alle aktiven Positionen von John Boyce

Ehemalige bekannte Positionen von John Boyce

Unternehmen	Position	Ende
Exosome Diagnostics GmbH Exosome Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Bio-Techne Corp., Exosome Diagnostics GmbH is a German company that engages in research and development in the field of biotechnology. The company is based in Martinsried, Germany. The CEO of the company is Gary Michael Stapleton.	Vorstandsvorsitzender	-

Sehen Sie sich die Erfahrung von John Boyce im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von John Boyce im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
Exosome Diagnostics, Inc. Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA.	Health Services
Exosome Diagnostics GmbH Exosome Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Bio-Techne Corp., Exosome Diagnostics GmbH is a German company that engages in research and development in the field of biotechnology. The company is based in Martinsried, Germany. The CEO of the company is Gary Michael Stapleton.	Commercial Services